Pinellas Eye Center — Pinellas Park, Florida

Pinellas Eye Center is a clinical research site located in Pinellas Park, Florida, United States 33781.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Pinellas Eye Center has participated in 1 clinical trials.

Therapeutic areas: Keratoconjunctivitis Sicca.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pinellas Park

Browse all research sites in Florida · View every site in Pinellas Park

• Radiant Research
• DMI Research
• Synexus Clinical Research US Inc
• Eye Associates of Pinellas
• GSK Investigational Site
• Radiant Research-St.Petersburg
• Pfizer Investigational Site
• Advent Clinical Research Centers
• Southeast Eye Institute, P.A. dba Eye Associates of Pinellas
• Belleair Research Center
• Sage Investigational Site
• Teva Investigational Site 13616

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pinellas Eye Center?

Pinellas Eye Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pinellas Eye Center conducted?

Pinellas Eye Center has 1 clinical trials on record. Their work covers Keratoconjunctivitis Sicca.

Is Pinellas Eye Center accredited by Crixeo Clinical Trials?

Pinellas Eye Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pinellas Eye Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.